Prescriber's Letter

61 - 75 of 77 Results

Sort Results:

Guideline: Cardiovascular Monitoring of Children and Adolescents With Heart Disease Receiving Stimulant Drugs (Correction) (2009) June 2008

Patient Education: Patient Handout to Go Along with Your MedGuide for ADHD Drugs June 2008

Commentary: Cardiovascular Screening and Monitoring Of Children and Adolescents Receiving ADHD Drugs June 2008

Guideline: Cardiovascular Monitoring of Children and Adolescents With Heart Disease Receiving Stimulant Drugs (2008) June 2008

Guideline: AAP Policy Statement on Cardiovascular Monitoring and Stimulant Drugs for ADHD (Addendum May 2008: On May 28, 2008, the American Academy of Pediatrics (AAP) released a statement on cardiovascular monitoring in children and adolescents taking ADHD medications. The AAP does not recommend screening ECGs unless the patient's history, family history, or the physical examination raises concerns.) June 2008

Article: American Heart Assoc statement is raising a furor because it implies that ALL children on ADHD drugs need an ECG June 2008

Article: Some Daytrana (methylphenidate) patches are falling off September 2007

Article: Sparlon and Daytrana for ADHD February 2006

Chart: Drug Treatment for Attention Deficit Hyperactivity Disorder February 2006

Other: Safety Concerns of ADHD Drugs August 2005

Article: People are hearing about potential safety concerns with Concerta August 2005

Article: treating ADHD in ADULTS October 2004

Other: Attention-deficit Hyperactivity Disorder in Adults: An Update October 2004

Other: New Product: Concerta (Extended-Release Methylphenidate) September 2000

Other: Natural Medicines for Attention Deficit-Hyperactivity Disorder (ADHD) September 2000